Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related conditions, today provided shareholders with an update on its ...

Surrey batter vows to use lacklustre stint as an opening batter as fuel for a return to the England Test side | ESPN.com ...